Quibim, a well-established health tech company, focuses on enhancing patient healthcare through the translation of medical imaging data into meaningful information. As of 2021, Quibim transitioned from scientific discovery to global commercialization, using years' worth of quantitative imaging biomarker research. Since then, Quibim has seen increased expansion globally and increased staffing numbers. Quibim has added the use of cutting-edge artificial intelligence in the analysis of MRI, CT, and PET imaging to provide its life science and healthcare partners with improved information to support their decision making.

Large amounts of imaging data can be managed, coordinated, and analyzed by hospitals and research institutions using Quibim's cloud-based, tissue-agnostic platform. Its software-as-a-service (SaaS) model provides modern technology such as medical devices, and collaborations with life sciences organizations assist in the development of predictive algorithms and the identification of unmet clinical needs. With ISO 27001:2022 recognition and compliance with HIPAA and GDPR regulations, data security is essential to business operations.

To create a new generation of predictive biomarker panels using radiomics and deep learning to combine multiple kinds of omics data, Quibim has developed machine learning algorithms that improve the accuracy of diagnoses, track the progression of disease, and create personalized therapies, allowing for the use of precision medicine. Through innovation, secure technology, and a global presence, Quibim is changing how imaging supports both clinical and research advancements by providing healthcare providers with the tools they need to make faster, more accurate and individualized treatment decisions.

Products Offered by Quibim

QP-Prostate^®

An AI-powered tool called Quibim's QP-Prostate^® was created to improve prostate MRI reading for quicker and more accurate cancer detection. Prostate cancer is the second most common type of cancer among men, but a growing need for imaging has resulted in false or other delays in diagnosis from radiologists. QP-Prostate helps radiologists by automating important processes and ensuring compliance with PI-RADS v2.1 guidelines while accurately delineating the prostate, including peripheral, transitional, and central zones, and seminal vesicles.

The software creates a fully automated workflow from image acquisition to reporting by easily connecting with PACS and fusion biopsy systems. Its AI-QUALTM module detects artifacts and confirms optimal scans by evaluating picture quality according to PI-QUAL v2 criteria. QP-Prostate combines AI insights with radiologist annotations to identify concerning lesions, provide confidence-based classifications, and produce structured, PI-RADS-compliant reports.

Clinically proven to increase detection sensitivity by up to 10%, QP-Prostate helps radiologists in accurately identifying intermediate and high-grade aggressive tumors. Strong accuracy and specificity are ensured by its double-validation with biopsy data. The solution meets international standards with regulatory certifications from CE, UKCA, and 510(k). By combining state-of-the-art artificial intelligence with useful workflow integration, QP-Prostate will assist healthcare professionals in providing more rapid, precise, and consistent prostate cancer diagnostic assessments of patients. As a result, patient care will be improved, and clinicians' work will be simplified.

QP-Brain^®

An AI-powered program called Quibim's QP-Brain^® was created to improve brain MRI processing and assist in the early identification of neurological disorders. Accurate evaluation of brain anatomy and lesions is crucial, given the growth in neurodegenerative diseases. QP-Brain^® gives clinicians accurate, objective insights by automating the assessment of brain volumes across 132 areas and assessing white matter hyperintensities (WMH).

The software makes it possible to detect tumors and brain atrophy when comparing a person's medical records to an appropriate standard database of other patients' records. This provides help for physicians during diagnosis, tracking disease progression, and monitoring changes over time. Visual assessment is backed up by detailed volumetry and WMH reports, which lower human error and improve diagnostic confidence.

QP-Brain^® integrates seamlessly within radiology workflows by offering easier reporting and combining many different types of complex imaging into one business report that provides easy to understand, measurable information. It has received both CE and UKCA Marks and has also received 510(k) clearance, so it may be sold globally and complies with the GDPR and HIPAA laws.

The combination of artificial intelligence with clinical validation allows for faster, more accurate and more consistent assessments of brain health through QP-Brain^®. Its automated analysis improves radiology productivity, promotes better patient care, and offers useful resources for neurological disorder research and monitoring, assisting physicians in making better judgments.

QP-Liver^®

An AI-powered program called Quibim's QP-Liver^® improves liver MRI analysis for the detection and treatment of diffuse liver disorders. Millions of people worldwide suffer from diseases like iron overload and non-alcoholic fatty liver disease (NAFLD), which present major clinical difficulties. Without requiring a biopsy, QP-Liver^® offers non-invasive, exact measurement of iron and liver fat, allowing early detection and careful monitoring.

Using multi-echo chemical shift (MECSE) sequences, the software automatically analyzes abdominal MRI data to produce detailed voxel-wise maps of iron and fat. By recognizing the liver and entire abdomen through artificial intelligence-based segmentation, it does away with manual labor and guarantees accurate, consistent measurements. R2* and proton density fat fraction (PDFF) biomarkers provide exact outcomes that closely correspond to digital pathology and biopsy data.

QP-Liver^® creates structured quantitative reports that compare patient data with normative references and easily interacts with PACS and clinical procedures. Its worldwide regulatory conformity is confirmed by the CE and UKCA markings. QP-Liver^® supports radiologists and clinicians to manage liver disease in a personalized way through automated analysis, accurate quantification, and transparent reporting. QP-Liver^® improves clinical decision-making and patient care by improving diagnostic confidence, simplifying workflows, and allowing accurate non-invasive hepatic MRI.

Dr. Ángel Alberich-Bayarri | CEO & Co-Founder

“Quibim’s QP-Insights® is a one-stop platform that handles, indexes, stores, and harmonizes imaging data, ensuring standardized quality and minimizing variability across equipment manufacturers.”